Exclusive-Kennedy's Health Officials Explored US Ban Of Some Widely Used Antidepressants, Sources Say

Published Date: 13 May 2026

U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F....

Read Full News

Latest News

Lactate Dehydrogenase and Outcomes in HFrEF

Insights on the relationship between LDH and clinical outcomes from the GALACTIC-HF, a phase 3, randomized, placebo-controlled trial evaluating omecamtiv mecarbil in HFrEF.

The Only Sleep Study I Can Get Is a PAT

The in-home, patient-friendly peripheral arterial tonometry test seems to be the wave of the future for diagnosing obstructive sleep apnea. Dr Aaron Holley discusses this wearable device known as PAT.

US NIH Names John Powers III as Acting Director Of Infectious Disease Institute

The National Institutes of Health appointed Dr. John Powers III as ⁠acting director of its infectious disease institute, the agency's website showed on...

Drug-Induced Alopecia: When to Suspect and How to Treat It

Experts highlight clues that help identify drug-induced alopecia and outline treatment strategies tailored to the underlying mechanism and pattern of hair loss.

Inside the Quest to Make Old Cells Young Again

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype artists want to admit.

Latin America’s HIV Mortality Gap: Can Research Close It?

Latin America continues to lag the global decline in HIV-related mortality, prompting experts to identify research priorities targeting advanced HIV and gaps in care.

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Todays Updates

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Teplizumab Approved for Pediatric Stage 3 Type 1 Diabetes

The drug was previously approved for stage 2 T1D.

One in Four Teen Girls and Young Women at Risk for PMOS

Findings suggest young females should be assessed and, if at risk, monitored.

Palopegteriparatide Benefits Sustained Beyond 3 Years

Final results from the PaTHway trial show the long-acting parathyroid hormone therapy enabled patients with hypoparathyroidism to achieve independence from high-dose calcium and vitamin D supplements.

Testosterone Prescribing Often Ignores Guidelines

Only 12% of patients prescribed testosterone underwent appropriate diagnostic testing, and overprescribing was common in a single-center US study.

Encaleret Shows Rapid Response in ADH1

The oral modulator of the calcium-sensing receptor targets the causes of ADH1, significantly improving serum and urine calcium levels.

Off-Label Rxs: Thinking Out of the Box for Skin Diseases

Off-label alternatives for FDA-approved therapies can be as effective, cheaper, and in some cases safer despite never having been submitted for regulatory approval.

Latest News

Insights on the relationship between LDH and clinical outcomes from the GALACTIC-HF, a phase 3, randomized, placebo-controlled trial evaluating omecamtiv mecarbil in HFrEF.

The in-home, patient-friendly peripheral arterial tonometry test seems to be the wave of the future for diagnosing obstructive sleep apnea. Dr Aaron Holley discusses this wearable device known as PAT.

The National Institutes of Health appointed Dr. John Powers III as ⁠acting director of its infectious disease institute, the agency's website showed on...

Experts highlight clues that help identify drug-induced alopecia and outline treatment strategies tailored to the underlying mechanism and pattern of hair loss.

Reversing cellular age isn’t science fiction, but the biology is more complicated than either the skeptics or the hype artists want to admit.

Latin America continues to lag the global decline in HIV-related mortality, prompting experts to identify research priorities targeting advanced HIV and gaps in care.

News All Time

Visible Light and Skin Health: What Clinicians Should Know

An international expert panel issues consensus recommendations on visible light photoprotection, highlighting its emerging role in skin health and disease.

Several Markers May Flag Severity of Peanut Allergy in Kids

Several biomarker measures such as wheal diameters on skin prick tests, peanut-specific antibody levels, and basophil activation differ between children with severe vs mild reactions to peanuts.

MHRA Approves Nipocalimab for Myasthenia Gravis

The MHRA has authorised nipocalimab for generalised myasthenia gravis in adults and adolescents aged 12 and over, based on evidence from two clinical studies.

WHO's Tedros Says Uganda Should Reconsider Congo Border Closure Over Ebola

The director-general of the World Health Organization said on Monday ⁠that Uganda should reconsider its decision to close its border with Democratic ⁠Republic of Congo...

AI Brings Oxygen Therapy Closer to Autopilot

EMILY.AI uses AI to personalize oxygen delivery in real time, aiming for safer saturation control and fewer manual adjustments.

Ontario Researchers Discover Promising Antibiotic

McMaster University researchers have discovered a new antibiotic that kills drug-resistant bacteria through a previously unrecognized mechanism of action.

TNFi Use in Early Peripheral SpA Outperforms Methotrexate

‘These data [from the phase 3 SPARTACUS trial] support the importance of early diagnosis and early treatment before structural damage,’ said one expert not involved in the research.

Lyme Primer: How the HHS Strategy Stacks Up To Science

Experts support targeting ticks but caution against the long-term use of antibiotics.

FDA Approves First New Sunscreen Option in Two Decades

Bemotrizinol protects against both ultraviolet A and B rays, has low absorption through the skin, and is safe for adults and children 6 months and older, according to the FDA.

US Adds $38 Million for Ebola as CDC Warns Outbreak Could Match 2014

The United States said on Friday it would provide an additional $38 million for Ebola response efforts, as the CDC warned that without strong public health interventions the...

Whole Blood vs Components: No Survival Benefit in Trauma

Prehospital transfusion with whole blood was not linked to reduced 30-day mortality compared with prehospital transfusion with blood components in patients with traumatic hemorrhage, a phase 3 trial finds.

New POCUS for Residents: Should Hospitalists Join?

Few attending hospitalists have formal training in point-of-care ultrasound, but more are eager to learn.

Hospitalists Leading Health Informatics in the Digital Age

Technology in hospitals is changing quickly, having clinicians at the helm makes a difference.

Health Experts to Screen US Wastewater for Disease Outbreaks During World Cup

Epidemiologists will be busy this summer sifting through sewage and social media with the goal of keeping soccer fans and the public safe from severe illness during the...

'They're Betting Our Herd': Texas Ranchers Question USDA as Screwworm Returns

Like many ranchers in South Texas, Susan Storey said nightmarish screwworm outbreaks were among her first childhood memories. Now 62, she still recalls seeing wriggling...

Oral Glucocorticoids Linked to Higher Candidemia Risk

The use of oral glucocorticoids increases the odds of developing candidemia in a dose-dependent fashion; effects are strongest in users with inflammatory bowel disease.

Recommended News For You

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

Getting More Done With Less Blood.

A study on lung cancer provides additional proof of the value of screening.

Trump slashed US cancer research by 31 percent: Senate report

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer

O. A. J. Simpson passes away from cancer.

Recommended Articles For You

Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength 

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients 

From Bruises to Blood Clots: Everything You Need to Know about Hematoma  

Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

2.

'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link

3.

Millions of men could benefit from faster scan to diagnose prostate cancer

4.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

5.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

1.

Modern Approaches to Detecting Residual Disease: Clinical Utility and Future Trends

2.

A Closer Look at the Effects of Sickle Cell on Eyesight

3.

Uncovering the Role of Pap Smear in Oncology: A New Frontier in Cancer Detection

4.

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care

5.

Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

3.

Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World

4.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

5.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot